This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jounce Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fabien DÉPIS: Innovator in Chemokine Research
Introduction
Fabien DÉPIS is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of biomedicine, particularly in the development of antibodies that target specific receptors in the human body.
Latest Patents
DÉPIS holds a patent for "Antibodies that Bind to Human Chemokine (C-C Motif) Receptor 8 (CCR8)." This innovation is crucial for advancing therapeutic strategies in various diseases, including cancer and autoimmune disorders. He has 1 patent to his name, showcasing his expertise and dedication to scientific research.
Career Highlights
Currently, Fabien DÉPIS is employed at Jounce Therapeutics, Inc., a company focused on developing innovative cancer therapies. His work at Jounce Therapeutics has positioned him as a key player in the biopharmaceutical industry, contributing to groundbreaking research and development.
Collaborations
DÉPIS has collaborated with esteemed colleagues, including Leonard G Presta and Changyun Hu. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that drives innovation.
Conclusion
Fabien DÉPIS is a prominent figure in the field of chemokine research, with a focus on developing targeted therapies. His contributions through patents and collaborations reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile